NYSEArca - Nasdaq Real Time Price USD

Principal Investment Grade Corporate Active ETF (IG)

19.95

-0.11

(-0.55%)

As of 10:38 AM EDT. Market Open.

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it will release its first-quarter 2024 financial results on Thursday, May 9, 2024.

PR Newswire 2 hours ago

INSM
-3.72%
Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago

Many investors define successful investing as beating the market average over the long term. But the risk of stock...

Simply Wall St. 4 hours ago

ANIK
-1.14%
APUE Continues to Pull in Inflows; ETF Fund Flows as of April 24

The ActivePassive US Equity ETF saw its assets under management jump 14% in a single day.

etf.com 17 hours ago

VFFSX

VFIAX

VFINX
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

MENLO PARK, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report first quarter financial results and provide a corporate update on May 1, 2024. The company will also host a conference call that day at 5:00 p.m. Eastern Time (2:00 p.m. Pacific Time). Conference Call Information Participants must register in advance of the conference call by clicking here. Upon registering, each participant will receive a dial-in number, and a u

GlobeNewswire 18 hours ago

CORT
-0.18%
Accel Entertainment (ACEL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Accel Entertainment (ACEL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks yesterday

ACEL
-1.15%
Accel Entertainment, Inc. to Announce First Quarter 2024 Financial Results

CHICAGO, April 24, 2024--Accel Entertainment, Inc. (NYSE: ACEL) today announced it will release its financial and operating results for the first quarter ended March 31, 2024, after market close on May 8, 2024. The company will host a conference call at 5:30 PM ET / 4:30 PM CT that same day to discuss these results.

Business Wire yesterday

ACEL
-1.15%
Visionary Holdings Inc. Announcement of Management Change

Visionary Holdings Inc. (the "Company") (NASDAQ: GV), a private education provider with technology of artificial intelligence and life science on the cutting edge, with subsidiaries in Canada and market partners in China, today announced on April 22, 2024, the Board appointed Mr. Zhong Chen as its new chief executive officer, effective immediately.

PR Newswire yesterday

GV
-1.27%
Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study

Corcept (CORT) reports positive data from the open-label portion of the phase III GRACE study evaluating relacorilant for treating patients with Cushing's syndrome.

Zacks yesterday

CORT
-0.18%
CEL-SCI Appoints Mario Gobbo to Its Board of Directors

VIENNA, Va., April 23, 2024--CEL-SCI appoints Mario Gobbo to its Board of Directors.

Business Wire 2 days ago

CVM
-1.35%
Should You Invest in the First Trust NASDAQ Semiconductor ETF (FTXL)?

Sector ETF report for FTXL

Zacks 2 days ago

FTXL
Actively Managed ETFs What Investors Need to Know

Eight of the largest 10 active ETFs are outperforming their respective category peers.

etf.com 2 days ago

JEPI

DFUV

JPST
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome

MENLO PARK, Calif., April 22, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders by modulating the effects of the hormone cortisol, today announced positive results from the open-label portion of the pivotal Phase 3 GRACE trial of its proprietary selective cortisol modulator relacorilant in patients with all etio

GlobeNewswire 3 days ago

CORT
-0.18%
Senstar Technologies Full Year 2023 Earnings: US$0.06 loss per share (vs US$0.17 profit in FY 2022)

Senstar Technologies ( NASDAQ:SNT ) Full Year 2023 Results Key Financial Results Revenue: US$32.8m (down 7.8% from FY...

Simply Wall St. 5 days ago

SNT
+0.25%
IHT S-3 OPENS DOORS FOR DIVERSIFICATION CAPITAL INFUSION

Phoenix, AZ, April 19, 2024 (GLOBE NEWSWIRE) -- InnSuites Hospitality Trust (NYSE American: IHT) IHT management announces Filing an S-3, allowing the potential to offer and sell up to 1,000,000 shares of IHT common stock, without par value (“Common Stock”), of the Company. The S-3 prospectus includes the details as it relates to shares of IHT Common Stock that may be offered and issued from time to time. The amount of gross proceeds received will depend upon the number of shares issued, and the

GlobeNewswire 5 days ago

IHT
+0.82%
TSMC Beats on Q1 Earnings, Shares Fall: ETFs in Focus

Taiwan Semiconductor Manufacturing (TSM) returned to sales and earnings growth after four consecutive quarters of declines on a year-over-year basis.

Zacks 5 days ago

TSM

SPGI

SMH
Senstar Technologies Announces Filing and Availability of 2023 Annual Report on Form 20-F

Senstar Technologies Corporation (NASDAQ: SNT), a leading international provider of comprehensive physical, video and access control security products and solutions, announced today that its Annual Report on Form 20-F for the year ended December 31, 2023 has been filed with the Securities and Exchange Commission ("SEC") and is available on the Company's website https://senstartechnologies.com in the Investors section under SEC Filings, as well as from the SEC's website www.sec.gov.

PR Newswire 6 days ago

SNT
+0.25%
/C O R R E C T I O N -- Senstar Technologies Corporation/

Senstar Technologies Corporation (successor to Senstar Technologies Ltd.) (NASDAQ: SNT), a leading international provider of comprehensive physical, video and access control security products and solutions, today announced its financial results for the three and twelve months ended December 31, 2023. Management will hold an investors' conference call later today (at 9 a.m. Eastern Time) to discuss the results.

PR Newswire 6 days ago

SNT
+0.25%
Inflation Is Making Investing’s Free Lunch Expensive

Asset allocation ETFs reversing after decades of progress.

etf.com 6 days ago

RAAX

LCR

AOK
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that the Company plans to issue its first quarter 2024 financial results after the close of the market on Wednesday, May 8, 2024 and hold its investor conference call on the same day, at 5:30 p.m. ET to discuss its financial results and business highlights. The conference call can be accessed by dialing 1-888-886-7786 (

GlobeNewswire 6 days ago

ANIK
-1.14%
Jan van Eck Receives 2024 ETF.com Lifetime Achievement Award

NEW YORK, April 18, 2024--VanEck CEO Jan van Eck was last night honored with the Lifetime Achievement Award at the 2024 ETF.com Awards.

Business Wire 7 days ago

GDX

ANGL

Performance Overview

Return	IG	Category
YTD	-3.21%	-0.01%
1-Year	+0.47%	+4.69%
3-Year	-3.99%	-1.75%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Principal Investment Grade Corporate Active ETF (IG)

Related ETF News

Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024

Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago

APUE Continues to Pull in Inflows; ETF Fund Flows as of April 24

Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call

Accel Entertainment (ACEL) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release

Accel Entertainment, Inc. to Announce First Quarter 2024 Financial Results

Visionary Holdings Inc. Announcement of Management Change

Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study

CEL-SCI Appoints Mario Gobbo to Its Board of Directors

Should You Invest in the First Trust NASDAQ Semiconductor ETF (FTXL)?

Actively Managed ETFs What Investors Need to Know

Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome

Senstar Technologies Full Year 2023 Earnings: US$0.06 loss per share (vs US$0.17 profit in FY 2022)

IHT S-3 OPENS DOORS FOR DIVERSIFICATION CAPITAL INFUSION

TSMC Beats on Q1 Earnings, Shares Fall: ETFs in Focus

Senstar Technologies Announces Filing and Availability of 2023 Annual Report on Form 20-F

/C O R R E C T I O N -- Senstar Technologies Corporation/

Inflation Is Making Investing’s Free Lunch Expensive

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024

Jan van Eck Receives 2024 ETF.com Lifetime Achievement Award

Performance Overview